Skip to main content
Sex Differences in Autoimmune Disease Susceptibility: Drs. Yusof and Robinson

Dr. Yusof interviews Dr. Robinson about a

Dr. John Cush RheumNow

5 years 4 months ago
Sex Differences in Autoimmune Disease Susceptibility: Drs. Yusof and Robinson Dr. Yusof interviews Dr. Robinson about abstract OP0013, presented at the virtual #EULAR2021 meeting. https://t.co/IPe6lMM7NQ
RT @Janetbirdope: How common is RA ILD? @RheumNow #EULAR2021 @eular_org

Janet Pope Janetbirdope

5 years 4 months ago
How common is RA ILD? @RheumNow #EULAR2021 @eular_org
RT @Janetbirdope: RA ILD is NOT a needle in a haystack! Older age& makes & COPD is a risk MUC5B gene SNIP are r

Janet Pope Janetbirdope

5 years 4 months ago
RA ILD is NOT a needle in a haystack! Older age& makes & COPD is a risk MUC5B gene SNIP are risks NOT ACPA. 7-10% will have relevant RA ILD. Are you ready to identity & treat it? @RheumNow #EULAR2021 BI RA ILD symposium @eular_org https://t.co/4mS6Jejjqk
RT @drdavidliew: Glad to present my own work in the irAE session #EULAR2021

PET/CT can help show us that PMR irAEs are

David Liew drdavidliew

5 years 4 months ago
Glad to present my own work in the irAE session #EULAR2021 PET/CT can help show us that PMR irAEs are a distinct phenomenon, not just generalised immune activation... and if we can understand PMR irAEs maybe we can understand a bit about classical PMR as well! OP0194 @RheumNow https://t.co/d4yjExjES3
RT @Janetbirdope: Leave my MTX alone says pt & #rheumatologist if pt has chronic ILD. Acute pneumonia from MTX is NO

Janet Pope Janetbirdope

5 years 4 months ago
Leave my MTX alone says pt & #rheumatologist if pt has chronic ILD. Acute pneumonia from MTX is NOT chronic ILD in RA @RheumNow @eular_org #EULAR2021 #BoehringerIngelheim RA ILD silent killer symposium https://t.co/IQTINuUpVq
RT @Stiddyo: #POS0196 1 year results of the SELECT-PsA 2 study: Inadequate responders to ≥1bDMARD subjected to #upadac

Paul Studenic Stiddyo

5 years 4 months ago
#POS0196 1 year results of the SELECT-PsA 2 study: Inadequate responders to ≥1bDMARD subjected to #upadacitinib maintained efficacy throughout week 56 (74% of pts completed 1-year) #EULAR2021 @RheumNow https://t.co/xpqhzgeI6q
RT @Janetbirdope: Complements that are low in #SLE pregnancy have POORER fetal outcomes. What happens to C3 & C4 in

Janet Pope Janetbirdope

5 years 4 months ago
Complements that are low in #SLE pregnancy have POORER fetal outcomes. What happens to C3 & C4 in pregnancy? They should ⬆️ by 28% C3, 11% C4 in 1st Trimester ⁦@RheumNow⁩ #EULAR2021 POS0103. So order C3&C4 early in pregnancy in SLE & follow! https://t.co/FpHHj74e43
RT @RichardPAConway: Great talks on comorbidities in RA at #EULAR2021 today. What do we struggle most with in RA managem

Richard Conway RichardPAConway

5 years 4 months ago
Great talks on comorbidities in RA at #EULAR2021 today. What do we struggle most with in RA management? @RheumNow
RT @Janetbirdope: Can well controlled SLE pt taper #Belimumab? Maybe. Single site w 48 pts & over 2 yrs 44% could ta

Janet Pope Janetbirdope

5 years 4 months ago
Can well controlled SLE pt taper #Belimumab? Maybe. Single site w 48 pts & over 2 yrs 44% could taper esp if on #plaquenil. This may change my practice but will follow pts closely POS0107 ⁦@RheumNow⁩ #EULAR2021 ⁦@eular_org⁩ https://t.co/8WCrt11ubV
Cardiovascular (CV) disease remains the leading cause of mortality in rheumatoid arthritis (RA). A number of studies progressed our knowledge in the session Rheumatoid arthritis - comorbidity and clinical aspects – I on Thursday at EULAR 2021.
×